17 - University of Michigan
CURRICULUM VITAE
Mack Thomas Ruffin, IV
Dr. Max and Buena Lichter Research Professor of Family Medicine
Department of Family Medicine, University of Michigan Health System
1018 Fuller St., Ann Arbor, MI 48104-1213
734.998.7120 x 310
mruffin@umich.edu
|Title and Contents |Page 1 |
|Education and Training |Page 2 |
|Certification and Licensure |Page 2 |
|Academic, Administrative, and Clinical Appointments |Page 2 |
|Research Interests |Page 3 |
|Grants |Page 3 |
|Honors and Awards |Page 6 |
|Memberships in Professional Societies |Page 6 |
|Editorial Positions, Boards and Peer-Review Service |Page 6 |
|Teaching |Page 7 |
|Committee, Organizational, and Volunteer Service |Page 8 |
|Consulting Positions |Page 10 |
|Visiting Professorships, Seminars, and Extramural Invited Presentations |Page 10 |
|Bibliography |Page 15 |
Education and Training
8/1971 - 6/1975 Henrico High School, Richmond, Virginia.
8/1975 - 12/1978 University of Virginia, Charlottesville, Virginia.
6/1978 - 5/1980 BSE (Biomedical Engineering), Duke University, Durham, North Carolina.
8/1980 - 5/1984 MD, Medical College of Virginia, Richmond, Virginia.
7/1984 - 6/1987 Family Practice Residency, Bowman Gray School of Medicine,
Baptist Hospital, Winston-Salem, North Carolina.
7/1987 - 6/1989 MPH (Epidemiology), University of Minnesota, Minneapolis, Minnesota.
7/1987 - 6/1989 Family Practice Fellowship in Academic Medicine and Clinical Investigation,
Department of Family Practice and Community Health,
University of Minnesota, Minneapolis, Minnesota.
Certification and Licensure
Certification:
1984 Diplomat, National Board of Medical Examiners.
2008 - 2018 Diplomat, American Board of Family Medicine.
1993 - 2003 Certificate of Added Qualifications in Sports Medicine, American Board of
Family Medicine.
03/15 - 04/18 DEA registration.
Licensure:
12/14/89 - 04/30/18 Medical License, State Medical Board, State of Michigan.
12/14/89 - 04/30/18 Controlled Substance License, State of Michigan.
Academic, Administrative, and Clinical Appointments
Academic Appointments:
6/1989 - 12/1989 Instructor, Department of Family Practice and Community Health, University of Minnesota, Minneapolis, Minnesota.
1/1990 - 8/1996 Assistant Professor, Department of Family Practice, University of Michigan Medical School, Ann Arbor, Michigan.
1/1990 - present Assistant Research Scientist, Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan.
9/1996 - 8/2005 Associate Professor, Department of Family Medicine, University of Michigan Medical School, Ann Arbor, Michigan.
9/2005 - present Professor, Department of Family Medicine, University of Michigan Medical School, Ann Arbor, Michigan.
Administrative Appointments:
1/1990 - present Member, Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan.
7/2004 - 2/2016 Associate Chair for Research Programs, Department of Family Medicine, University of Michigan Medical School, Ann Arbor, Michigan.
01/2016 - present Member, Advisory Committee on Academic Promotions and Tenure, Department of Family Medicine, University of Michigan Medical School,
Ann Arbor, Michigan.
Clinical Appointments:
1/1990 - present Staff Physician, University of Michigan Health System, Ann Arbor, Michigan.
1/1990 - present Staff Physician, Chelsea Community Hospital, Chelsea, Michigan.
Research Interests
1) Cancer prevention via primary and secondary strategies
2) Molecular and genetic markers of cancer
3) Changing patient health behaviors related to cancer prevention
4) Changing physician practices in the delivery of cancer prevention
Grants
Present and Active:
NIH/NCI (R01CA152413-01A1)
Decision Aid to Technologically Enhance Shared Decision Making (DATES)
Co-I (PI: Jimbo), 04/01/11-03/31/15 (no cost ext 03/31/17), approx. $2,441,668 direct costs
Previous:
NIH/NCI (CA001618-01)
Preventive Oncology Academic Award
PI, 08/92-07/97, approx. $412,177 direct costs
NIH/NCI
Education Program in Cancer Prevention and Control
Co-I, 09/94-08/97, approx.. $1,419,603 direct costs
NIH/NCI (CA66223-02)
Environmental Factors Influencing Breast Cancer
Co-I, 09/94-08/98, approx. $150,000 direct costs
Michigan Department of Community Health, Cancer Section
Michigan Kiosk System
Co-I, 09/96-09/99, approx. $1,000,000 direct costs
NIH/NCI (CA68291-01)
Retinoids and Intermediate Biomarkers for CIN II & III
PI, 09/01/95-06/30/01, approx. $662,940 direct costs
NIH/NCI
Tailored Interventions for Multiple Risk Behaviors
Co-I (PI: Strecher), 05/01/99-04/30/03, approx. $2,359,226 direct costs
Michigan Department of Community Mental Health
Developing New Messages to Promote Colorectal Cancer Screening
PI, 10/01/00-9/30/01, approx. $250,000 direct costs
CDC
Clinical Validation of Molecular Signatures of Cervical Cancer
PI (subcontract UM); PI: Unger (CDC), 09/01/01-9/24/04, approx. $423,454 total costs
Michigan Department of Community Mental Health
Multi-media Decision Aid to Promote Colorectal Cancer Screening
PI, 01/01/02-09/30/03 (no cost ext 09/30/04), approx. $230,000 direct costs
NIH/NCI
HPV Integration as a Biomarker for CIN Behavior
PI (subcontract UM); PI: Lancaster (WSU), 06/01/02-05/31/04, approx. $120,000 total costs
NIH/NCI (K24 CA80846-010)
Cancer Chemoprevention and Mentoring Clinical Researchers
PI, 07/01/99-06/30/04 (no cost ext 06/30/05), approx. $518,516 direct costs
NIH (R21 CA 104484-01)
Prompting and Reminding at Encounters for Prevention (PREP)
Co-I (PI: Nease), 09/12/03-08/31/05 (no cost ext 8/31/06), approx. $382,500 direct costs
Center for Health Communications Research, University of Michigan
Cancer Screening Adherence through Tech-Enhanced Shared Decision Making (CSATS)
Co-I (PI: Jimbo), 02/01/06-01/31/07, approx. $50,000 total costs
NIH/NCI (CA074648 05)
University of Michigan CCOP Research Base (Supplement)
Co-I (PI: Brenner), 06/01/04-05/31/07, approx. $1,130,171 direct costs
CDC (MM-0789-04/04)
Family Assessment of Risk Evaluation (FARE) Trial
PI, 10/01/03-09/30/07 (no cost ext 09/30/08), approx. $1,199,081 total costs
NIH/NCI (P50 CA105632)
Correlates of Abnormal Pap Smears in AppalachiaPI (Core U of M); Center PI: Paskett (OSU), 09/01/03-08/31/07 (no cost ext 08/31/09), approx. $533,482 total costs
CTSA
Streamlining Cancer Screening through Interactive Technology (SCanIT)
Co-I (PI: Jimbo), 11/01/07-10/31/08 (no cost ext 05/30/10), approx. $100,000
NIH/NCI (CA086400 06)
Great Lakes-New England Clinical Epidemiology and Validation Center
Co-I (PI: Brenner), 03/01/05-02/28/10, approx. $5,983,193 direct costs
CDC (2005-14735)
Early Detection Research Network: Clinical Validation of Molecular Signatures of Cervical Cancer. Biorepository for Biomarker Studies of Cervical Cancer
PI: Ruffin, 09/22/05-09/22/11, approx. $1,055,617 direct costs
NIH (U34 DK084542-01)
The Impact of Family History and Genomics Based Risk Profiling on Primary Care
Co-I (PI: Roberts), 09/30/09-07/31/11 (no cost ext 04/30/12), approx. $748,451 total costs
NIH/NCI (CA080846-06A1)
Cancer Chemoprevention and Mentoring Clinical Researchers
PI: Ruffin, 08/22/06-07/31/11 (no cost ext 07/31/12), approx. $740,034 total costs
Blue Cross & Blue Shield of Michigan Foundation
Does Automatically Prompting Primary Care Providers about High-Risk Family Histories Increase Referrals or Discussions about Risk for Certain Diseases and Where Appropriate, Referrals for Genetic Counseling
Co-I (PI: Zazove), 03/01/11-02/29/12 (no cost ext 02/28/13), approx. $10,000 total costs
NIH (1RO1 CA120381A1)
A Mediterranean Diet in Colon Cancer Prevention
Co-I (PI: Djuric), 01/01/07-12/31/12, $224,180
NIH (5R01CA116487-05)
Enhancing Colorectal Cancer Screening in Primary Care
Consultant (PI: Paskett), 05/01/07-02/28/13, approx. $409,644 annual direct costs
*NIH/NCI (1R01CA154455-01)
Serum Glycoprotein Markers of Cancer Using an Ion Mobility/mass
Co-I (PI: Lubman), 01/11/11-12/31/13 (no cost ext 12/31/14), approx. $312,911 direct costs
*grant ends 12/31/14; Dr. Ruffin’s effort ended 12/31/13
*NIH/NCI (1P50CA130810-01A2)
Translational Research in GI Cancer
Co-I (PI: Brenner), 09/13/10-08/31/15, approx. $2,193,817 total costs
*grant ends 08/31/15; Dr. Ruffin’s effort ended 05/31/14
NIH/NCI (2P50CA105632-06)
Reducing Cervical Cancer in Appalachia
Co-I (PI: Paskett), 05/01/10-04/30/15, approx. $150,000 direct costs
NIH/NCI (CA086400)
Great Lakes New England Clinical Epidemiology and Validation Center
Co-I (PI: Brenner), 07/01/10-06/30/15, approx. $298,416 direct costs
Pending:
NIH
Implementation of BMI2 in U of M Clinics: An Effectiveness Study
Co-Investigator (PI: Resnicow), 09/01/15-08/31/20, $3,859,906 total costs
NIH
Translational Research in GI Cancer
Co-Investigator / Core D Director (PI: Brenner), 09/01/16-08/31/21, $1,787,799
NIH
Protein Markers of Pancreatic Cancer in Serum
Co-Investigator (PI: Lubman), 09/01/16-08/31/19, $1,176,610
NIH/NICHD
Improving Contraceptive Care for Women with Chronic Conditions: A Novel, Web-Based Decision Aid in Primary Care
Co-Investigator (PI: Wu), 09/01/16-08/31/21, $156,000
NIH
Identification of Microbiome Based Markers to Improve Colorectal Cancer Detection
Principal Investigator, 04/01/17-03/31/20, $1,700,228
Honors and Awards
1971 Eagle Scout
1977 Intermediate Honors, University of Virginia.
1980 Magna Cum Laude, Duke University.
1999 Outstanding Medical Alumnus, Medical College of Virginia.
1999 Best Research Presentation, Michigan Family Practice Research Day XXII.
2001 Regional Finalist, White House Fellows Program.
2008 Token of Appreciation from Medical Students (TAMS) Award, University of Michigan Medical School.
2011 Dr. Max and Buena Lichter Research Professor of Family Medicine.
2014 League of Research Excellence, University of Michigan Medical School.
2014 Fellow; Association of Departments of Family Medicine (2015-2016); Leawood, KS.
Memberships in Professional Societies
1987 - present Society of Teachers of Family Medicine,
Reviewer and Mentor of Grant Generating Project.
1987 - present North American Primary Care Research Group, Board Member 1988-1989.
1990 - present American Society of Preventive Oncology.
1997 - present International Society of Cancer Chemoprevention.
2000 - present American Association for Cancer Research.
Editorial Positions, Boards, and Peer-Review Service
1987 - present North American Primary Care Research Group Annual Meeting, Reviewer.
1991 - present American Journal of Gastroenterology, Ad Hoc Reviewer.
1992 - 1999 Family Medicine, Editorial Board.
1999 - present Cancer Epidemiology, Biomarkers, and Prevention, Editorial Board.
2000 - present Nutrition and Cancer, Ad Hoc Reviewer.
2000 - present The Journal of Histochemistry and Cytochemistry, Ad Hoc Reviewer.
Teaching
1989 Outpatient Attending Physician for Medical Students and Residents, Department of Family Practice and Community Health, University of Minnesota, 400-500 hours/year.
1990 - 2000 Attending Physician, Family Practice Obstetrical Inpatient Service, University
of Michigan Medical School, 1-2 months/year.
1990 - present Outpatient Attending Physician for Medical Students and Residents, Department of Family Medicine, University of Michigan Medical School, 400-500 hours/year.
1991 - 1993 Research Preceptor, Kimberly Burney, Master thesis.
1993 - 1995 Course Director, Clinical Epidemiology, Fourth Year Medical Student
Advanced Science Elective, University of Michigan Medical School.
1994 - 2005 Research Mentor, Michael Fetters MD, faculty, RWJ Generalist Award.
1996 - 1998 Cancer Information Exchange, Advisory Committee, Annual Conference on Cancer Prevention, Amelia Island, Florida.
1996 - 1998 Research Preceptor, Marian Ryan MD, Resident project.
1996 - 1998 Research Preceptor, Johanna Whitman MD, Resident project.
1996 - 1998 Research Preceptor, Scott Paluska MD, Resident project.
1996 - 1998 Research Preceptor, William Borgos MD, Resident project.
1996 - 1998 Research Preceptor, Carrie Rubsteinsen, Undergraduate Honors thesis, Summer Biomedical Research Award.
1996 - 2001 Coordinator of Family Medicine Resident Scholarly Projects.
1996 - present Course Director, Midwinter Family Practice Update, annual week-long CME
conference in Boyne, Michigan.
1996 - present Monthly Small Group Discussion with Third Year Medical Students on Preventive Services.
1996 - 2004 Annual Lecture to Second Year Medical Students on Smoking Cessation.
1996 - 2005 Research Mentor, Joanne Bailey CNM, Nursing Doctoral thesis.
1997 - 1999 Research Preceptor, Suzanne Dixon MS, Masters thesis.
1997 - 2000 Research Preceptor, Jennifer Fahner, Undergraduate Honors thesis, Summer research award, Best Student Presentation Michigan Family Medicine Research Day 1999.
2000 - 2010 Research Mentor, Suzanna Zick ND, faculty, K07 awarded.
2002 - 2003 Research Preceptor, Bryan Holcomb MD, Summer medical student research award, Best Student Presentation Michigan Family Medicine Research Day 2000.
2002 - 2010 Research Mentor, Jorge Marrero MD, faculty, K23 awarded.
2002 - 2011 Research Mentor, Donald Nease MD, faculty, R21 and R03 grants from NCI.
2002 - 2004 Research Mentor, Darya Alexander MD, Resident project.
2002 - 2004 Research Mentor, David Lien MD, Resident project.
2002 - 2004 Research Mentor, Kathryn Harmes MD, Resident project.
2005 - 2010 Research Mentor, Amy Ferketich, Ohio State University, faculty, K07 awarded.
2008 BME 599 Innovative Design Team Course.
2010 - present Research Mentor, Alisa Young and Marisyl de la Cruz, Resident Project, Best Poster and Research Presentation, 2011 Michigan Family Medicine Research Day.
Committee, Organizational, and Volunteer Service
Institutional:
University:
1997 - 2000 Vice-Provost's Academic Affairs Advisory Committee, University of Michigan, Ann Arbor, Michigan.
2000 - 2001 University of Michigan Senate Assembly, Budget Study Committee,
Ann Arbor, Michigan.
2002 - 2005 University Senate, University of Michigan, Ann Arbor, Michigan.
Medical School:
1995 - 2000 University of Michigan Breast Care Guidelines Committee, Ann Arbor,
Michigan.
1995 - 1997 Life Long Advisory Committee for M-Care, Ann Arbor, Michigan.
1997 - 1999 Adult Preventive Services Guidelines Committee, Chair, University of
Michigan Medical Center, Ann Arbor, Michigan.
1997 - 2008 University of Michigan Comprehensive Cancer Center Protocol Review Committee, Ann Arbor, Michigan. Chair 2004-2008.
1997 - 2005 University of Michigan Medical School Advisory Council on Clinical Research, Ann Arbor, Michigan. Vice-Chair 2003-2004. Chair 2004-2005.
2012 - 2013 Geriatrics Center and Institute of Gerontology Review Committee, University of Michigan Medical Center, Ann Arbor, Michigan.
2012 MICHR Clinical Trials Office (MCTO) Advisory Board Committee, University of Michigan Medical Center, Ann Arbor, Michigan.
Department:
1990 - 2000 Patient Care Committee, Briarwood Family Practice Center, Department of Family Medicine, University of Michigan, Ann Arbor, Michigan.
1996 - 2001 Advisory Committee on Promotion and Tenure, Department of Family Medicine, University of Michigan, Ann Arbor, Michigan. Chair 1998-2001.
Regional:
2005 - present Michigan Cancer Consortium, Cervical Cancer Advisory Committee.
2011 - 2015 Michigan Cancer Consortium, Colorectal Cancer Special Project.
National:
1995 - present Grant Reviewer, American Academy of Family Physicians Foundation.
1998 - present American Cancer Society, Study Section for Cancer Control Career Development Awards For Primary Care Physicians. Study Section Chair 2001-present.
1999 Aetna and Smith Kline Beecham Quality Care Research Fund Review Panel.
2000 NCI Scientific Review Group Subcommittee G – Education.
2003 - present NCI Scientific Review Special Emphasis Panel – Loan Repayment Program.
2008 CDC Scientific Review Group – HPV Vaccine.
2011 NIH Scientific Review Group – HPV Vaccine Trial.
2015 Member, ADFM/NAPCRG "RSVP" Fellowship Taskforce.
2016 - 2018 Member, American Society of Preventive Oncology Executive Committee.
2016 CDC Scientific Review Group – HPV Vaccination Update.
International:
1998 - present Grant Reviewer, Dutch Cancer Society.
Volunteer Service:
1984 - present Boy Scouts of America, Troop 425 Committee Member (Chair 2008-present), Chelsea, Michigan. Physician for National Jamboree and National Order of the Arrow Conference.
1990 - present Team Physician, Chelsea High School, Chelsea, Michigan.
1991 - 2000 Volunteer Physician, Lyn Hadley Memorial and Shelter Association Clinic, Ann Arbor, Michigan.
1993 - 1995 Title XV; Breast and Cervical Cancer Screening Program, Public Education Task Force, Washtenaw County, Ann Arbor, Michigan.
1994 - 1999 Executive Board, Planned Parenthood of Mid-Michigan, Ann Arbor, Michigan.
1997 - present Travel Soccer Coach, Chelsea Soccer Club, Chelsea, Michigan.
Consulting Positions
2000 - 2004 Maxia, USA Clinical Advisory Board, San Diego, California.
Visiting Professorships, Seminars, and Extramural Invited Presentations
1989 Visiting Professor, Department of Preventive Medicine, Mayo Clinic,
Rochester, Minnesota.
1990 Visiting Professor, Department of Family Medicine, University of North
Carolina, Chapel Hill, North Carolina.
1991 Visiting Professor, Northeastern Ohio Universities, College of Medicine,
Canton, Ohio.
1994 Visiting Professor, Department of Family and Community Medicine,
University of Minnesota, Minneapolis, Minnesota.
2001 Visiting Professor, University of Minnesota Comprehensive Cancer Center, Minneapolis, Minnesota.
2001 - 2002 Visiting Scientist, Centers for Disease Control and Prevention, Atlanta, Georgia.
2002 Visiting Professor, University of California San Diego Comprehensive Cancer Center and the Department of Family and Preventive Medicine, San Diego, California.
2003 Visiting Professor, Department of Family Medicine, Ohio State University, Columbus, Ohio.
2004 Visiting Professor, Case Western Reserve Comprehensive Cancer Center, Cleveland, Ohio.
2004 Visiting Professor, Ohio State University Comprehensive Cancer Center, Columbus, Ohio.
2005 Visiting Professor, Department of Family Medicine, University of Wisconsin, Madison, Wisconsin.
2011 Visiting Professor, Department of Family Medicine, University of North Carolina, Chapel Hill, North Carolina.
2011 Visiting Professor, UNC Linehurst Comprehensive Cancer Center, Chapel Hill, North Carolina.
Extramural Invited Presentations:
1. Ruffin MT, May 1990, Adults’ knowledge on child restraint devices. Annual Meeting of the Society of Teachers of Family Medicine, Seattle, Washington.
2. Ruffin MT, May 1990, National survey of family physicians’ practice of screening for cervical cancer: Preliminary findings. North American Primary Care Research Group, Denver, Colorado.
3. Ruffin MT, November 1990, Characteristics of a productive research environment. Fellowship Program, Department of Family Medicine, University of North Carolina, Chapel Hill, North Carolina.
4. Ruffin MT, November 1990, Cancer early diagnosis in Primary Care Practice. Grand Rounds, Department of Family Medicine, University of North Carolina, Chapel Hill, North Carolina.
5. Ruffin MT, January 1991, Critical appraisal of the medical literature. NEOUCOM Fellowship Activity in Academic Medicine, Canton, Ohio.
6. Ruffin MT, May 1991, Colposcopy and cervicography: A survey of family physicians practices and needs. North American Primary Care Research Group, Quebec, Canada.
7. Ruffin MT, May 1991, Physician and nurse agreement on cervical cancer screening practices. North American Primary Care Group, Quebec, Canada.
8. Zazove P, Reed BD, Ruffin MT, Gorenflo DW, Gregoire L, Smith MA, May 1991, Evaluation of the presence of human papillomavirus in a community-based population: Comparison of clinical examination, Papanicolaou smear, DNA probe, and PCR testing. North American Primary Care Research Group, Quebec City, Quebec, Canada.
9. Ruffin MT, Bland CJ, Schwenk TL, Brown DM, Niedhardt F, November 1991, Developing and maintaining research conducive environments. Annual Meeting of the Association of American Medical Colleges, Washington, D.C.
10. Zazove P, Mehr DR, Ruffin MT, Klinkman M, April 1992, Geriatric preventive care services workshop. Annual Meeting of the Society of Teachers of Family Medicine, St. Louis, Missouri.
11. Ruffin MT, Sheets KJ, April 1993, Sources of funding of Primary Care research. Annual Meeting of the Society of Teachers of Family Medicine, San Diego, California.
12. Rock CL, Randall DL, Ruffin MT, August DA, Sake GA, June 1993, Carotenoids and estrogen receptor status in breast cancer. 10th International Symposium on Carotenoids, Trondheim, Norway.
13. Ruffin MT, Koon K, Gorenflo D, November 1993, Patients’ interpretations of probability statements. North American Primary Care Research Group, San Diego, California.
14. Rock CL, Randall DL, Ruffin MT, August DA, March 1994, Carotenoids and estrogen receptor status in breast cancer. American Society of Preventive Oncology, Bethesda, Maryland.
15. Ruffin MT, Burney KD, Krishnan K, Brenner DE, March 1995, Adherence to aspirin in a phase 1 chemoprevention trial. American Society of Preventive Oncology, Houston, Texas.
16. Ruffin MT, Krishnan K, Kraus E, Kelloff G, Boone C, Crowell J, Vaerten M, Burney K, Bromberg J, Rock C, Boland C, Brenner DE, March 1995, Aspirin as a chemopreventive agent for colorectal cancer: Lowest dose of aspirin to suppress rectal mucosal prostaglandins. American Association for Cancer Research, Toronto, Ontario, Canada.
17. Ruffin MT, September 1997, Controversies in preventive services: Breast cancer screening and prostate cancer screening. Metropolitan Hospital Fall Update, Grand Rapids, Michigan.
18. Ruffin MT, October 1997, Screening for colorectal cancer. Toledo Hospital Family Practice Residency, Toledo, Ohio.
19. Ruffin MT, November 1997, To screen or not to screen: The persistent dilemma. Advances in Urology, Dearborn, Michigan.
20. Ruffin MT, September 1998, Put prevention into practice. Lakeland Hospital, St. Joseph, Michigan.
21. Ruffin MT, November 2001, Diet, HPV and cervical dysplasia. Centers for Disease Control and Prevention, Atlanta, Georgia.
22. Ruffin MT, Fetters MD, Power D, March 2003, RCT of a new interactive electronic program to promote colorectal cancer screening. ASPO 27th Annual Meeting, Philadelphia, Pennsylvania.
23. Ruffin, MT, Bailey JM, Normolle D, Michael C, Fonde K, Johnston C, Reed B, Brenner BE, Unger E, Kmak D, March 2003, Topical all-trans retinoic acid for CIN II/III. ASPO 27th Annual Meeting, Philadelphia, Pennsylvania.
24. Ruffin MT, Fetters MD, Crawford K, Creswell JW, Power D, March 2003, Development of an interactive educational electronic program to promote colorectal cancer screening. ASPO 27th Annual Meeting, Philadelphia, Pennsylvania.
25. Ruffin, MT, Bailey JM, Normolle D, Michael C, Fonde K, Johnston C, Reed B, Brenner BE, Unger E, Kmak D, May 2003, Topical all-trans retinoic acid for CIN II/III. Michigan Family Medicine Research Day, Michigan State University, Lansing, Michigan.
26. Ruffin MT, Fetters MD, Crawford K, Creswell JW, Power D, May 2003, Development of an interactive educational electronic program to promote colorectal cancer screening. Michigan Family Medicine Research Day, Michigan State University, Lansing, Michigan.
27. Ruffin MT, Fetters MD, Power D, May 2003, Trial of a new interactive electronic program to promote colorectal cancer screening (poster presentation). Family Practice Research Day, Michigan State University, Lansing, Michigan.
28. Ruffin MT, Normolle D, Heath DD, Bailey JM, Murray SI, Boggs ME, Crowell J, Rock CL, Brenner DE, October 2003, Dose escalation of curcumin in healthy adults (poster presentation). AACR Frontiers in Cancer Prevention Research, Phoenix, Arizona.
29. Ruffin MT, Bailey JM, Normolle D, Michael C, Bieniasz M, Fonde K, Johnston C, Reed BD, Brenner DE, Kmak D, Unger ER, October 2003, Topical all-trans retinoic acid in high grade squamous intraepithelial lesions (poster presentation). AACR Frontiers in Cancer Prevention Research, Phoenix, Arizona.
30. Holcomb B, Bailey JM, Crawford K, Ruffin MT IV, February 2004, Adults' knowledge and behaviors related to human papillomavirus infection (poster presentation). 21st International Papillomavirus 2004 Conference, Mexico City, Mexico.
31. Bailey J, Bieniasz M, Ruffin MT, Unger E, Porter D, Kmak D, February 2004, An exploratory study of the association between perceived social stressors, HPV infection and cervical intraepithelial neoplasia (poster presentation). 21st International Papillomavirus 2004 Conference, Mexico City, Mexico.
32. Ruffin MT, Bailey JM, Schipper M, Normolle D, Michael C, Bieniasz M, Fonde K, Johnston C, Reed B, Brenner DE, Kmak D, Unger ER, Lee DR, Swan D, February 2004, Topical all-trans retinoic acid in high grade squamous intraepithelial lesions (poster presentation). 21st International Papillomavirus 2004 Conference, Mexico City, Mexico.
33. Ruffin MT, May 7, 2004, Family history tool for PCPs or Family Assessment of Risk Evaluation (FARE) Trial. 2004 Annual Michigan Statewide Genetics Symposium, One Ford Place, Detroit, Michigan.
34. Ruffin MT, May 21, 2004, Cervical cancer: Chemoprevention and biomarker development. Case Cancer Center Blood Club Meeting, University Hospitals of Cleveland and CWRU School of Medicine, Cleveland, Ohio.
35. Ruffin MT, May 21, 2004, Changing cancer screening practices of community primary care practices. Case Cancer Center Blood Club Meeting, University Hospitals of Cleveland and CWRU School of Medicine, Cleveland, Ohio.
36. Ruffin MT, June 23, 2004, Colorectal Cancer Prevention: Screening. Memorial Hospital, South Bend, Indiana.
37. Ruffin MT, September 9, 2004, Barriers to colorectal screening. Dialogue for Action: Fulfilling the promise of colorectal cancer screening in Michigan, Lansing, Michigan.
38. Ruffin MT IV, Bailey JM, Swan DC, Patel S, Lee DR, Unger, ER, May 2005, Absence of human papillomavirus in amniotic fluid (poster presentation). 22nd International Papillomavirus 2005 Conference, Vancouver, BC Canada.
39. Ruffin MT, March 16, 2006, Office systems and organization. Dialogue for Action in Colorectal Cancer Screening, Baltimore, Maryland.
40. Jimbo M, Ruffin M, Nease D, Fetters, MD, Strecher V, Saunders E, October 2006, Cancer screening adherence through technology-enhanced shared decision making (poster presentation). 34th Annual Meeting of the North American Primary Care Research Group, Tucson, Arizona.
41. Ruffin M, November 10, 2006, Colon rectal cancer screening. 20th Annual Family Practice Weekend & Sports Medicine Conference, Huntington, West Virginia.
42. Post DM, Ruffin R, Reiter P, Hade EM, deMoor J, Paskett ED, July 2008, The relationship between self-identity and depression in women from Appalachia Ohio. NCI Cancer Health Disparities Summit 2008, Bethesda, Maryland.
43. Katz M, Ruffin M, Post D, Paskett ED, October 28, 2008, Human Papillomavirus (HPV) vaccine acceptance in Ohio Appalachia. American Public Health Association 136th Annual Meeting, San Diego, California.
44. Paskett ED, Katz M, Reiter P, Oliveri JM, Lehman A, Rhoda D, Post D, Ruffin M, October 28, 2008, Socioeconomic barriers to Pap smear utilization among Ohio Appalachian women. American Public Health Association 136th Annual Meeting, San Diego, California.
45. Ruffin M, DeGraffinreid C, Hicks M, Katz M, Hade E, Paskett ED, October 28, 2008, Human Papillomavirus (HPV) vaccine knowledge and attitudes among women in Appalachia Ohio. American Public Health Association 136th Annual Meeting, San Diego, California.
46. Reiter P, Paskett ED, Katz M, Ferketich AK, Ruffin M, October 28, 2008, Appalachian self-identity and its effects on cervical cancer screening and risky sexual behavior among women in Ohio Appalachia. American Public Health Association 136th Annual Meeting, San Diego, California.
47. Post DM, Ruffin M, Reiter P, Hade EM, deMoor J, Paskett ED, July 08, The relationship between self-identity and depression in women from Appalachia, Ohio. NCI Cancer Health Disparities Summit 2008, Bethesda, Maryland.
48. Ruffin MT IV, Hade EM, Gorsline MR, DeGraffinreid CR, Katz ML, Kobrin SC, Paskett ED, September 11, 2008, HPV papillomavirus vaccine knowledge and acceptance among women in Appalachia (poster presentation). 27th International Papillomavirus Conference, Berlin, Germany.
49. de la Cruz MD, Young AP, Ruffin MT IV, September 11, 2008, Use of HPV testing in low risk women ages 30-65. 27th International Papillomavirus Conference, Berlin, Germany.
50. Zick SM, Bostick RM, Ruffin M, Turgeon K, Wright BD, Brenner D, December 12, 2011, Ginger supplementation and the expression of NF-kB in the normal-appearing colorectal mucosa of patients at high risk of colorectal cancer: results from a pilot randomized, controlled trial. 50th Anniversary PSNA Meeting, Hilo, Hawaii.
51. Ruffin MT IV, April 3, 2014, HPV and cancer. Columbus Chapter of Oncology Nursing Society (CCONS) 25th annual Spring Conference Kaleidoscope of Oncology Care, Columbus, Ohio.
52. Ruffin MT IV, May 20, 2015, Adding Value and Quality to Family Medicine with Research. Beaumont Health - 2nd Annual Family Medicine Research Day, Troy, Michigan.
Other Presentations:
1. Ruffin MT, September 1990, September 1991, September 1992, and September 1993, Nonorthopedic sports injuries. Office Procedures for Primary Care Physicians Conference.
2. Ruffin MT, Rifat SF, September 1992 and 1993, March 1993 and 1994, Preparticipation sports physical examinations. Office Procedures for Primary Care Physicians Conference, University of Michigan, Ann Arbor, Michigan.
3. Ruffin MT, February 1992, Controversies in clinical prevention and screening: Prostate cancer and colon cancer. Family Practice Update, Harbor Springs, Michigan.
4. Ruffin MT, March 1992 and 1997, Putting prevention into your practice. Spring Family Practice Review, Ann Arbor, Michigan.
5. Ruffin MT, March 1993 and 1997, Chronic fatigue: Diagnosis and management. Spring Family Practice Review, Ann Arbor, Michigan.
6. Ruffin MT, February 1999, March 1999, July 1999, March 2000, Chemoprevention: A new strategy in Breast Cancer Prevention. Department of Family Medicine CME courses, Boyne, Michigan; Ann Arbor, Michigan; Traverse City, Michigan.
7. Ruffin MT, December 1996 and February 2002, Review of malpractice cases. Department of Family Medicine CME courses, Boyne, Michigan and Ann Arbor Michigan.
8. Ruffin MT, February 2004, Update on new pap guidelines. Department of Family Medicine CME courses, Boyne, Michigan.
9. Ruffin MT, February 2004, HPV treatment: Update. Department of Family Medicine CME courses, Boyne, Michigan.
10. Ruffin MT, September 2004, Cancer prevention and screening: New issues and areas of controversy. Department of Family Medicine CME courses, Towsley Center, Ann Arbor, Michigan.
11. Ruffin MT, February 2005, NSAID/Cox inhibitors: Not so hot drugs. Department of Family Medicine CME courses, Boyne, Michigan.
12. Ruffin MT, February 2005, Dermatology review. Department of Family Medicine CME courses, Boyne, Michigan.
13. Ruffin MT, February 2005, Top ten patient oriented evidence-based medical articles for 2004. Department of Family Medicine CME courses, Boyne, Michigan.
14. Ruffin MT, January 2007, HPV vaccine. Department of Family Medicine CME courses, Boyne, Michigan.
15. Mack Ruffin, Suzanne O'Neill, Wendy Rubinstein, Nan Rothrock, Erin Starzyk, Jennifer Beaumont and Louise Acheson, December 2007, The distribution of family history risk for disease in primary care practices. Sixth AACR International Conference on Frontiers in Cancer Prevention Research, Philadelphia, Pennsylvania.
16. Ruffin MT, February 2008, Top five patient oriented evidenced-based medical articles 2007. Department of Family Medicine CME courses, Boyne, Michigan.
17. Ruffin MT, February 2008, Old and new agents for smoking cessation. Department of Family Medicine CME courses, Boyne, Michigan.
18. Katz ML, Heaner S, Reiter P, Ruffin M, Post D, Paskett ED, March 2008, Human Papillomavirus (HPV) vaccine acceptance among residents of Ohio Appalachia (poster presentation). American Society of Preventive Oncology, Bethesda, Maryland.
19. Ruffin MT, DeGraffinreid CR, Hicks M, Katz ML, Hade EM, Paskett ED, March 2008, Human Papillomavirus (HPV) vaccine knowledge and attitudes among women in Appalachia Ohio (poster presentation). American Society of Preventive Oncology, Bethesda, Maryland.
20. Dempsey AF, Abraham L, Dalton V, Ruffin M, March 2008, Reasons why parents do or do not get their daughters vaccinated against HPV. National Immunization Conference, Centers for Disease Control and Prevention, Atlanta, Georgia.
21. Dempsey AF, Abraham L, Dalton V, Ruffin M, May 2008, Reasons why parents do or do not get their daughters vaccinated against HPV. Pediatric Academic Societies National Meeting, Honolulu, Hawaii.
22. Post DM, Ruffin R, Reiter P, Hade EM, deMoor J, Paskett ED, July 2008, The relationship
between self-identity and depression in women from Appalachia, Ohio. NCI Cancer Health Disparities Summit 2008. Bethesda, Maryland.
23. Ruffin MT, November 2008, HPV – The Basics and Beyond. Gynecology, Cancer & Women, University of Michigan, School of Nursing conference, Ann Arbor, Michigan.
24. Ruffin MT, February 2009, Update on adolescent vaccine. Department of Family Medicine CME courses, Boyne, Michigan.
25. Ruffin MT, February 2009, Shingles update: Vaccine, diagnosis, & treatment. Department of Family Medicine CME courses, Boyne, Michigan.
26. Ruffin MT, December 2009, Update on HPV Vaccinations. 18th Annual Primary Health Care of Women (CME course), Ann Arbor, Michigan.
27. Ruffin MT, January 31, 2012, Screening for Lung Cancer. Department of Family Medicine MidWinter Family Medicine Update (CME course), Boyne, Michigan.
28. Ruffin MT, February 1, 2012, Health Issues of Children at Summer Camp, it is Not Wilderness Medicine. Department of Family Medicine MidWinter Family Medicine Update (CME course), Boyne, Michigan.
29. Ruffin MT, February 2, 2012, Fatty Acid Supplementation. Department of Family Medicine MidWinter Family Medicine Update (CME course), Boyne, Michigan.
30. Ruffin MT, June 18, 2012, Updates on Cancer Screening. Department of Family Medicine Northern Michigan Summer Conference (CME course), Bellaire, Michigan.
31. Ruffin MT, June 18, 2012, Screening Strategies for Lung Cancer. Department of Family Medicine Northern Michigan Summer Conference (CME course), Bellaire, Michigan.
32. Ruffin MT, June 18, 2012, Adult Vaccine Update. Department of Family Medicine Northern Michigan Summer Conference (CME course), Bellaire, Michigan.
33. Ruffin MT, June 19, 2012, HPV Vaccine and Screening. Department of Family Medicine Northern Michigan Summer Conference (CME course), Bellaire, Michigan.
34. Ruffin MT, June 19, 2012, Genetic Screening for Common Disease: Ready for Primary Care? Department of Family Medicine Northern Michigan Summer Conference (CME course), Bellaire, Michigan.
35. Cohen AJ, Lachance LL, Ruffin M, Zick SM, May 2013, Utilization of SNAP incentive programs for purchase of fruits and vegetables at Detroit farmers market. Fellows, Residents, or Student Research Works in Progress Poster. 46th STFM Annual Spring Conference, Baltimore, Maryland. (Poster)
36. Ruffin MT, October 3, 2013, Screening for Lung Cancer. Department of Family Medicine Updates in Family Medicine Conference (CME course), Ann Arbor, Michigan.
37. Ruffin MT, October 3, 2013, Integrating Lung Cancer Screening Into Your Practice. Department of Family Medicine Updates in Family Medicine Conference (CME course), Ann Arbor, Michigan.
38. Ruffin MT, February 6, 2015, New Options for Colon Cancer Screening. Department of Family Medicine MidWinter Family Medicine Update (CME course), Boyne, Michigan.
39. Ruffin MT, February 10, 2015, Hot Topics from the United States’ Preventive Services Task Force. Department of Family Medicine MidWinter Family Medicine Update (CME course), Boyne, Michigan.
40. Ruffin MT, February 11, 2015, Hepatitis C: New Screening Recommendations & Treatment. Department of Family Medicine MidWinter Family Medicine Update (CME course), Boyne, Michigan.
41. Ruffin MT, February 11, 2015, Screening for Sexually Transmitted Infections. Department of Family Medicine MidWinter Family Medicine Update (CME course), Boyne, Michigan.
42. Van Der Wouden C, Carere A, Green RC, Ruffin M, Roberts S, March 2015. Consultation with Primary Care Providers following Direct-to-Consumer Genetic Testing: Correlates of Consumer Satisfaction. (Poster presentation) American College of Medical Genetics and Genomics 2015 Annual Clinical Genetics Meeting, Salt Lake City, Utah.
43. Choxi H, Plegue M, Rockwell P, Ruffin M, April 26, 2015, Impact of United States Preventative Services Task Force Guideline Recommendations for Hepatitis C screening on Primary Care Physicians’ Ordering. (Poster presentation) 48th Annual STFM Spring Conference, Orlando, Florida.
44. Ursu A, Sen A, Ruffin MT IV, April 27, 2015. Cervical Cancer Screening Guidelines and Rates of Sexually Transmitted Infection Screening. (Distinguished Paper) 48th Annual STFM Spring Conference, Orlando, Florida.
Bibliography
Peer-Reviewed Journals and Publications: (6 between 1988-1989)
1. Ruffin MT, Hunter RE, Arendt EA. Exercise and secondary amenorrhea linked through endogenous opioids. Sports Med 1990;10(2):65-71.
2. Ruffin MT. Fibrolamellar hepatoma. Am J Gastroenterol 1990;85(5):577-81.
3. Ruffin MT, Van Noord GR. Improving the yield of endocervical elements in a Pap smear with the use of the cytology brush. Fam Med 1991;23(5):365-9.
4. Klinkman MS, Zazove P, Mehr DR, Ruffin MT. A criterion-based review of preventive health care in the elderly. Part 1. Theoretical framework and development of criteria. J Fam Pract 1992;34(2):205-24.
5. Zazove P, Mehr DR, Ruffin MT, Klinkman MS, Peggs JF, Davies TC. A criterion-based review of preventive health care in the elderly. Part 2. A geriatric health maintenance program. J Fam Pract 1992;34(3):320-47.
6. Ruffin MT, Kantor R. Adults' knowledge about the use of child restraint devices. Fam Med 1992;24(5):382-5.
7. Bland CJ, Ruffin MT. Characteristics of a productive research environment: Literature review. Acad Med 1992;67(6):385-97.
8. Ruffin MT, Sheets KJ. Primary care research funding sources. J Fam Pract 1992;35(3):281-7.
9. Ruffin MT, Kiningham RB. Anterior knee pain: The challenge of patellofemoral syndrome. Am Fam Phys 1993;47(1):185-94.
10. Ruffin M. Building integrated systems--medical informatics. Healthc Forum J 1993;36(2):47-50.
11. Green LA, Ruffin MT. Differences in management of suspected myocardial infarction in men and women. J Fam Pract 1993;36(4):389-93.
12. Smith MA, Ruffin MT, Lee LA. The rational management of labor. Am Fam Phys 1993;47(6):1471-81.
13. Reed BD, Zazove P, Gregoire L, Gorenflo DW, Lancaster WD, Ruffin MT. Factors associated with human papillomavirus infection in women encountered in community-based offices. Arch Fam Med 1993;2(12):1239-48.
14. Zazove P, Reed BD, Gregoire L, Gorenflo DW, Lancaster WD, Ruffin MT, Hruszczyk J. Presence of human papillomavirus infection of the uterine cervix as determined by different detection methods in a low-risk community-based population. Arch Fam Med 1993;2(12):1250-8.
15. Ruffin MT, August DA, Kelloff GJ, Boone CW, Weber BL, Brenner DE. Selection criteria for breast cancer chemoprevention subjects. J Cell Biochem 1993;17G(Suppl):231-41.
16. Elward KS, Goldstein AO, Ruffin MT. Fellowship training in Family Medicine: Results of a national survey. Fam Med 1994;26(6):376-81.
17. Rifat SF, Ruffin MT. Management of thyroid nodules. Am Fam Phys 1994;50(4):785-90.
18. Ruffin MT, Cohen M. Evaluation and management of fatigue. Am Fam Phys 1994;50(3):625-34.
19. Green LA, Ruffin MT. A closer examination of sex bias in the treatment of ischemic cardiac disease. J Fam Pract 1994;39(4):331-6.
20. Ruffin M. The Informatics Institute: why do we need it? Physician Exec 1994;20(10):39-40.
21. Woloshin KK, Ruffin MT, Gorenflo DW. Patient’s interpretation of qualitative probability statements. Arch Fam Med 1994;3(11):961-6.
22. Gorenflo DW, Ruffin MT, Sheets KJ. A multivariate model for specialty choice by medical students. J Fam Pract 1994;39(6):570-6.
23. Kreher NE, Hickner JM, Ruffin MT, Lin CS. Effect of distance and travel time on rural women's compliance with screening mammography: An UPRNET Study. J Fam Pract 1995;40(2):143-7.
24. Rifat SF, Ruffin MT, Gorenflo DW. Disqualifying criteria in a preparticipation sports evaluation. J Fam Pract 1995;41(1):42-50.
25. Ruffin MT, Ogaily MS, Johnston CM, Gregoire L, Lancaster WD, Brenner DE. Surrogate endpoint biomarkers for cervical cancer chemopreventive trials. J Cell Biochem 1995;23(Suppl):113-24.
26. Rock CL, Saxe GA, Ruffin MT, August DA, Schottenfeld D. Carotenoids, vitamin A, and estrogen receptor status in breast cancer. Nutr Cancer 1996;25(3):281-96.
27. Burney KD, Krishnan K, Ruffin MT, Zhang D, Brenner DE. Adherence to single daily dose of aspirin in a chemoprevention trial: An evaluation of self-report and microelectronic monitoring. Arch Fam Med 1996;5(5):297-300.
28. Porter AT, Zimmerman J, Ruffin M, Chernew M, Callaghan C, Davis R, Lee F, Montie J, Swanson GM, Oesterling JE. Recommendations of the first Michigan conference on prostate cancer. Urology 1996;48(4):519-33.
29. Ruffin MT, Krishnan K, Rock CL, Normolle D, Vaerten MA, Peters-Golden M, Crowell J, Kelloff G, Boland CR, Brenner DE. Suppression of human colorectal mucosal prostaglandins: Determining the lowest effective dose. J Natl Cancer Inst 1997;89(15):1152-60.
30. Doukas DJ, Fetters M, Ruffin MT, McCullough LB. Ethical considerations in the provision of controversial screening tests. Arch Fam Med 1997;6(5):486-90.
31. Krishnan K, Ruffin MT, Brenner DE. Colon cancer chemoprevention: Clinical development of aspirin as a chemopreventive agent. J Cell Biochem 1997;28-29(Suppl):148-58.
32. Rock CL, Lovalvo JL, Emenhiser C, Ruffin MT, Flatt SW, Schwartz SJ. Bioavailability of beta-carotene is lower in raw than in processed carrots and spinach in women. J Nutr 1998;128(5):913-6.
33. Krishnan K, Ruffin MT, Brenner DE. Clinical models of chemoprevention for colon cancer. Hematol Oncol Clin North Am 1998;12(5):1079-113.
34. Krishnan K, Ruffin MT 4th, Brenner DE. Cancer chemoprevention. A new way to treat cancer before it happens. Prim Care 1998;25(2):361-79.
35. Ruffin MT, Lancaster WD. Clinical models of chemoprevention for cervical cancer. Hematol Oncol Clin North Am 1998;12(5):1115-34.
36. Reed BD, Ruffin MT, Gorenflo DW, Zazove P. The psychosexual impact of human papillomavirus cervical infections. J Fam Pract 1999;48(2):110-6.
37. Ruffin MT. Screening for prostate cancer. J Fam Pract 1999;48(8):581-2.
38. Drewnowski A, Henderson SA, Hann CS, Barratt-Fornell A, Ruffin M. Age and food preferences influence dietary intakes of breast care patients. Health Psychol 1999;18(6):570-8.
39. Ruffin MT, Gorenflo DW, Woodman B. Predictors of screening for breast, cervical, colorectal, and prostatic cancer among community-based primary care practices. JABFP 2000;13(1):1-10.
40. Ruffin MT, Baron J. Recruiting subjects in cancer prevention and control studies. J Cell Biochem 2000;77(S34):80-3.
41. Rock CL, Michael CW, Reynolds RK, Ruffin MT. Prevention of cervix cancer. Crit Rev Oncol Hematol 2000;33(3):169-85.
42. Krishnan K, Ruffin MT, Brenner DE. Chemoprevention for colorectal cancer. Crit Rev Oncol Hematol 2000;33(3):199-219.
43. Drewnowski A, Herderson SA, Hann CS, Berg WA, Ruffin MT. Genetic taste markers and preferences for vegetables and fruit of female breast care patients. J Am Diet Assoc 2000;100(2):191-7.
44. Ruffin MT, Rock CL. Do antioxidants still have a role in the prevention of human cancer? Curr Oncol Rep 2001;3(4):306-13.
45. Krishnan K, Ruffin MT, Normolle D, Shureiqi I, Burney K, Bailey J, Peters-Golden M, Rock CL, Boland CR, Brenner DE. Colonic mucosal prostaglandin E2 and cyclooxygenase expression before and after low aspirin doses in subjects at high risk or at normal risk for colorectal cancer. Cancer Epidemiol Biomarkers Prev 2001;10(5):447-53.
46. Rock CL, Moskowitz, A, Huizar B, Saenz CC, Clark JT, Daly TL, Chin H, Behling C, Ruffin MT. High vegetable and fruit diet intervention in premenopausal women with cervical intraepithelial neoplasia. J Am Diet Assoc 2001;101(10):1167-74.
47. Bieniasz ME, Underwood D, Bailey J, Ruffin MT. Women’s feedback on a chemopreventive trial for cervical dysplasia. Appl Nurs Res 2003;16(1):22-8.
48. Ruffin MT. Family physicians' knowledge of risk factors for cervical cancer. J Women’s Health 2003;12(6):561-7.
49. Rockwell P. Steyers, T, Ruffin MT. Chaperone use by family physicians during the collection of a Pap smear. Ann Fam Med 2003;1(4):218-20.
50. Bailey JM, Bieniasz ME, Kmak D, Brenner DE, Ruffin MT. Recruitment and retention of economically underserved women to a cervical cancer prevention trial. Appl Nurs Res 2004;17(1):55-60.
51. Holcomb B, Bailey J, Crawford K, Ruffin MT. Adults' knowledge and behaviors related to human papillomavirus infection. JABFP 2004;17(1):26-31.
52. Krishnan K, Aoki T, Ruffin MT, Normolle DP, Boland CR, Brenner DE. Effects of low dose aspirin (81 mg) on proliferating cell nuclear antigen and Amaranthus caudatus labeling in normal-risk and high-risk human subjects for colorectal cancer. Cancer Detect Prev 2004;28(2):107-13.
53. Ruffin MT, Gorenflo DW. Interventions fail to increase screening rates in community-based primary care practices. Prev Med 2004;39(3):435-40.
54. Fetters MD, Ivankova NV, Ruffin MT, IV, Creswell JW. Developing a web site in primary care. Fam Med 2004;36(9):651-9.
55. Ruffin MT, Bailey JM, Normolle DP, Michael CW, Bieniasz ME, Kmak DC, Unger ER, Brenner DE. Low dose topical delivery of all-trans Retinoic Acid for CIN II and III. Cancer Epidemiol Biomarkers Prev 2004;13(12):2148-52.
56. Rajeevan MS, Swan DC, Nisenbaum R, Lee DR, Vernon SD, Ruffin MT, Horowitz IR, Flowers LC, Kmak D, Tadros T, Birdsong G, Husain M, Srivastava S, Unger ER. Epidemiologic and viral factors associated with cervical neoplasia in HPV-16-positive women. Int J Cancer 2005;115(1):114-20.
57. Steinau M, Lee DR, Rajeevan MS, Vernon SD, Ruffin MT 4th, Unger ER. Gene expression profile of cervical tissue compared to exfoliated cells: Impact on biomarker discovery. BMC Genomics 2005;6(1):64.
58. Zick SM, Blume A, Normolle D, Ruffin M. Challenges in herbal research: A randomized clinical trial to assess blinding with ginger. Complement Ther Med 2005;13(2):101-6.
59. Normolle D, Ruffin MT, Brenner D. Design of early validation trials of biomarkers. Cancer Inform 2005;1:25-31.
60. Jimbo M, Nease DE, Jr., Ruffin MT, IV, Gurpreet RK. Information technology and cancer prevention. CA Cancer J Clin 2006;56(1):26-36.
61. Lao CD, Ruffin MT IV, Normolle D, Heath DD, Murray SI, Bailey JM, Boggs ME, Crowell J, Rock CL, Brenner DE. Dose escalation of a curcuminoid formulation. BMC Complement Altern Med 2006;17(6):10.
62. Ruffin MT 4th, Bailey JM, Roulston D, Lee DR, Tucker RA, Swan DC, Unger ER. Human papillomavirus in amniotic fluid. BMC Pregnancy Childbirth 2006;6:28.
63. Steinau M, Rajeevan MS, Lee DR, Ruffin MT, Horowitz IR, Flowers LC, Tadros T, Birdsong G, Husain M, Kmak DC, Longton GM, Vernon SD, Unger ER. Evaluation of RNA markers for early detection of cervical neoplasia in exfoliated cervical cells. Cancer Epidemiol Biomarkers Prev 2007;16(2):295-301.
64. Ruffin MT, Fetters MD, Jimbo M. Preference-based electronic decision aid to promote colorectal cancer screening: results of a randomized controlled trial. Prev Med 2007;45(4):267-73.
65. Qiu Y, Patwa TH, Xu L, Shedden K, Misek DE, Tuck M, Jin G, Ruffin MT, Turgeon DK, Synal S, Bresalier R, Marcon N, Brenner DE, Lubman DM. Plasma glycoprotein profiling for colorectal cancer biomarker identification by lectin glycoarray and lectin blot. J Proteome Res 2008;7(4):1693-1703.
66. Demark-Wahnefried W, George SL, Switzer BR, Snyder DC, Madden JF, Polascik TJ, Ruffin MT 4th, Vollmer RT. Overcoming challenges in designing and implementing a phase II randomized controlled trial using a presurgical model to test a dietary intervention in prostate cancer. Clin Trials 2008;5(3):262-72.
67. Vareed SK, Kakarala M, Ruffin MT, Crowell JA, Normolle DP, Djuric Z, Brenner DE. Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects. Cancer Epidemiol Biomarkers Prev 2008;17(6):1411-7.
68. Wilkerson JE, Bailey JM, Bieniasz ME, Rock CL, Ruffin MT. Cervical cancer precursors, diet and bitter taste (6-n-propylthiouracil ‘PROP’) receptors. Open Nutr J 2008;2:51-3.
69. Zick SM, Djuric Z, Ruffin MT, Litzinger AJ, Normolle DP, Alrawi S, Feng MR, Brenner DE. Pharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol, and 6-shogaol and conjugate metabolites in healthy human subjects. Cancer Epidemiol Biomarkers Prev 2008;17(8):1930-6.
70. Paskett ED, Reeves KW, McLaughlin JM, Katz ML, McAlearney AS, Ruffin MT, Halbert CH, Merete C, Davis F, Gehlert S. Recruitment of minority and underserved populations in the United States: The Centers for Population Health & Health Disparities Experience. Contemp Clin Trials 2008;29(6):847-61.
71. Nease DE Jr, Ruffin MT 4th, Klinkman MS, Jimbo M, Braun TM, Underwood JM. Impact of a generalizable reminder system on colorectal cancer screening in diverse primary care practices: a report from the prompting and reminding at encounters for prevention project. Med Care 2008;46(9 Suppl 1):S68-73.
72. Zick SM, Ruffin MT, Lee J, Normolle DP, Siden R, Alrawi S, Brenner DE. Phase II trial of encapsulated ginger as a treatment for chemotherapy-induced nausea and vomiting. Support Care Cancer 2009;17(5):563-72.
73. Djuric Z, Bird CE, Furumoto-Dawson A, Rauscher GH, Ruffin MT 4th, Stowe RP, Tucker KL, Masi CM. Biomarkers of psychological stress in health disparities research. Open Biomark J 2008;1:7-19.
74. Demark-Wahnefried W, Polascik TJ, George SL, Switzer BR, Madden JF, Ruffin MT IV, Snyder DC, Owzar K, Hars V, Albala DM, Walther PJ, Robertson CN, Moul JW, Dunn BK, Brenner D, Minasian L, Stella P, Vollmer RT. Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men presurgery. Cancer Epidemiol Biomarkers Prev 2008;17(12):3577-87.
75. Li C, Simeone DM, Brenner DE, Anderson MA, Shedden KA, Ruffin MT, Lubman DM. Pancreatic cancer serum detection using a lectin/glyco-antibody array method. J Proteome Res 2009;8(2)483-92.
76. Wang C, O'Neill SM, Rothrock N, Gramling R, Sen A, Acheson LS, Rubinstein WS, Nease DE Jr, Ruffin MT 4th; for the Family Healthware™ Impact Trial (FHITr) group. Comparison of risk perceptions and beliefs across common chronic diseases. Prev Med 2009;48(2)197-202.
77. Ruffin MT IV, Creswell JW, Jimbo M, Fetters MD. Factors influencing choices for colorectal cancer screening among previously unscreened African and Caucasian Americans: Findings from a triangulation mixed methods investigation. J Community Health 2009;34(2):79-89.
78. Stoffel EM, Turgeon DK, Stockwell DH, Zhao L, Normolle DP, Tuck MK, Bresalier RS, Marcon NE, Baron JA, Ruffin MT, Brenner DE, Syngal S; Great Lakes-New England Clinical Epidemiology and Validation Center of the Early Detection Research Network. Missed adenomas during colonoscopic surveillance in individuals with Lynch Syndrome (hereditary nonpolyposis colorectal cancer). Cancer Prev Res 2008;1(6):470-5.
79. Stoffel EM, Turgeon DK, Stockwell DH, Normolle DP, Tuck MK, Marcon NE, Baron JA, Bresalier RS, Arber N, Ruffin MT, Syngal S, Brenner DE; Great Lakes New England Clinical Epidemiology and Validation Center of the Early Detection Research Network. Chromoendoscopy detects more adenomas than colonoscopy using intensive inspection without dye spraying. Cancer Prev Res 2008;1(7):507-13.
80. Wilkerson JE, Bailey JM, Bieniasz ME, Murray SI, Ruffin MT. Psychosocial factors in risk of cervical intraepithelial lesions. J Womens Health (Larchmt) 2009;18(4):513-8.
81. Patel D, Shih YJ, Newton DW, Michael CW, Oeth PA, Kane MD, Opipari AW, Ruffin MT, Kalikin LM, Kurnit DM. Development and evaluation of a PCR and mass spectroscopy-based (PCR-MS) method for quantitative, type-specific detection of human papillomavirus. J Virolog Methods 2009;160(1-2):78-84.
82. Dempsey AF, Abraham LM, Dalton V, Ruffin M. Understanding the reasons why mothers do or do not have their adolescent daughters vaccinated against human papillomavirus. Ann Epidemiol 2009;19(8):531-8.
83. Katz ML, Reiter PL, Heaner S, Ruffin MT, Post DM, Paskett ED. Acceptance of the HPV vaccine among women, parents, community leaders, and healthcare providers in Ohio Appalachia. Vaccine 2009;27(30):3945-52.
84. O’Neill SM, Rubinstein WS, Wang C, Yoon PW, Acheson LS, Rothrock N, Starzyk EJ, Beaumont JL, Galliher JM, Ruffin MT IV, for the Family HeathwareTM Impact Trial Group. Familial risk for common diseases in primary care: The Family HealthwareTM Impact Trial. Am J Prev Med 2009;36(6):506-14.
85. Reiter PL, Katz ML, Ferketich AK, Ruffin MT, Paskett ED. Appalachian self-identity among women in Ohio Appalachia. Journal of Rural Community Psychology 2009; E12(1).
86. Reiter PL, Katz ML, Ferketich AK, Ruffin MT, Paskett ED. Measuring cervical cancer risk: development and validation of the CARE Risky Sexual Behavior Index. Cancer Causes Control 2009;20(10):1865-71.
87. Paskett ED, McLaughlin JM, Reiter PL, Lehman AM, Rhoda DA, Katz ML, Hade EM, Post DM, Ruffin MT. Psychosocial predictors of adherence to risk-appropriate cervical cancer screening guidelines: A cross sectional study of women in Ohio Appalachia participating in the Community Awareness Resources and Education (CARE) project. Prev Med 2010;50(1-2):74-80.
88. Dempsey A, Cohn L, Dalton V, Ruffin M. Patient and clinic factors associated with adolescent human papillomavirus vaccine utilization within a university-based health system. Vaccine 2010;28(4):989-95.
89. Acheson LS, Wang C, Zyzanski SJ, Lynn A, Ruffin MT 4th, Gramling R, Rubinstein WS, Oʼneill SM, Nease DE Jr; for the Family HealthwareTM Impact Trial (FHITr) Group. Family history and perceptions about risk and prevention for chronic diseases in primary care: a report from the Family HealthwareTM Impact Trial. Genet Med 2010;12(4):212-8.
90. Djuric Z, Ellsworth JS, Ren J, Sen A, Ruffin MT 4th. A randomized feasibility trial of brief telephone counseling to increase fruit and vegetable intakes. Prev Med 2010;50(5-6):265-71.
91. McAlearney AS, Song PH, Rhoda DA, Tatum C, Lemeshow S, Ruffin M, Harrop JP, Paskett ED. Ohio Appalachian women's perceptions of the cost of cervical cancer screening. Cancer 2010;116(20):4727-34.
92. Dempsey A, Cohn L, Dalton V, Ruffin M. Worsening disparities in HPV vaccine utilization among 19-26 year old women. Vaccine 2011;29(3):528-34.
93. Carlos RC, Dempsey AF, Ruffin MT 4th, Patel DA, Straus CM, Kure A, Dalton VK. Feasibility of using maternal cancer screening visits to identify adolescent girls eligible for HPV vaccination. J Womens Health (Larchmt) 2010;19(12):2271-5.
94. Zick SM, Ruffin MT, Djuric Z, Normolle D, Brenner DE. Quantitation of 6-, 8- and 10-Gingerols and 6-Shogaol in human plasma by high-performance liquid chromatography with electrochemical detection. Int J Biomed Sci 2010;6(3):233-40.
95. Ruffin MT, Normolle DP, Evelegh MJ, Baron JA, Bresalier RS, Marcon NE, Syngal S, Turgeon DK, Tuck MK, Brenner DE. Rectal mucosal quantitative galactose oxidase-Schiff reaction as an early detection biomarker for colorectal cancer: comparison to fecal occult stool blood test. Cancer Biomark 2010-2011;8(2):109-12.
96. Rubinstein WS, OʼNeill SM, Rothrock N, Starzyk EJ, Beaumont JL, Acheson LS, Wang C, Gramling R, Galliher JM, Ruffin MT 4th. Components of family history associated with women's disease perceptions for cancer: A report from the Family Healthware™ Impact Trial. Genet Med 2011;13(1):52-62.
97. Ruffin MT 4th, Nease DE Jr, Sen A, Pace WD, Wang C, Acheson LS, Rubinstein WS, O'Neill S, Gramling R; for The Family History Impact Trial (FHITr) Group. Effect of preventive messages tailored to family history on health behaviors: The Family Healthware Impact Trial. Ann Fam Med 2011;9(1):3-11.
98. Patel DA, Unger ER, Walline H, Opipari AW, Lee DR, Flowers LC, Ruffin MT. Lack of HPV 16 and 18 detection in serum of colposcopy clinic patients. J Clin Virol 2011;50(4):342-4.
99. Carlos RC, Dempsey AF, Resnicow K, Ruffin M, Patel DA, Straus CM, Vanessa K D. Maternal characteristics that predict a preference for mandatory adolescent HPV vaccination. Hum Vaccin 2011;7(2):225-9.
100. Lin Z, Simeone D, Anderson MA, Brand R, Xie X, Shedden K, Ruffin MT, Lubman DM. A mass spectrometric assay for analysis of haptoglobin fucosylation in pancreatic cancer. J Proteome Res 2011;10(5):2602-11.
101. Owens KM, Marvin ML, Gelehrter TD, Ruffin MT 4th, Uhlmann WR. Clinical use of the Surgeon General's "My Family Health Portrait" (MFHP) Tool: opinions of future health care providers. J Genet Couns 2011;20(5):510-25.
102. Heymach JV, Shackleford TJ, Tran HT, Yoo SY, Do KA, Wergin M, Saintigny P, Vollmer RT, Polascik TJ, Snyder DC, Ruffin MT, Yan S, Dewhirst MW, Kunnamakkara AB, Aggarwal BB, Demark-Wahnefried W. Effect of low-fat diet on plasma levels of NF-{kappa}B-regulated inflammatory cytokines and angiogenic factors in men with prostate cancer. Cancer Prev Res (Phila) 2011;4(10):1590-8.
103. Ruffin MT 4th, Nease DE Jr. Using patient monetary incentives and electronically derived patient lists to recruit patients to a clinical trial. J Am Board Fam Med 2011;24(5):569-75.
104. Zick SM, Turgeon DK, Vareed SK, Ruffin MT, Litzinger AJ, Wright BD, Alrawi S, Normolle DP, Djuric Z, Brenner DE. Phase II study of the effects of ginger root extract on eicosanoids in colon mucosa in people at normal risk for colorectal cancer. Cancer Prev Res (Phila) 2011;4(11):1929-37.
105. Gargano JW, Nisenbaum R, Lee DR, Ruffin MT, Steinau M, Horowitz IR, Flowers LC, Tadros TS, Birdsong G, Unger ER. Age-group differences in human papillomavirus types and cofactors for cervical intraepithelial neoplasia 3 among women referred to colposcopy. Cancer Epidemiol Biomarkers Prev 2012;21(1):111-21.
106. Rubinstein WS, Acheson LS, Oʼneill SM, Ruffin MT 4th, Wang C, Beaumont JL, Rothrock N; for the Family Healthware Impact Trial (FHITr) Group. Clinical utility of family history for cancer screening and referral in primary care: A report from the Family Healthware Impact Trial. Genet Med 2011;13(11):956-65.
107. Dorman JS, Valdez R, Liu T, Wang C, Acheson LS, Ruffin M, Khoury M, Rubinstein W. Health beliefs among individuals at increased familial risk for type 2 diabetes: implications for prevention diabetes research and clinical practice. Diabetes Res Clin Pract 2012;96(2):156-62.
108. Sadigh G, Dempsey AF, Ruffin M, Resnicow K, Carlos RC. National patterns in human papillomavirus vaccination: An analysis of the National Survey of Family Growth. Hum Vaccin Immunother 2012;8(2):234-42.
109. Yurgelun MB, Goel A, Hornick JL, Sen A, Turgeon DK, Ruffin MT 4th, Marcon NE, Baron JA, Bresalier RS, Syngal S, Brenner DE, Boland CR, Stoffel EM. Microsatellite instability and DNA mismatch repair protein deficiency in lynch syndrome colorectal polyps. Cancer Prev Res (Phila) 2012;5(4):574-82.
110. Djuric Z, Ruffin MT 4th, Rapai ME, Cornellier ML, Ren J, Ferreri TG, Askew L, Sen A, Brenner DE, Turgeon DK. A Mediterranean dietary intervention in persons at high risk of colon cancer: Recruitment and retention to an intensive study requiring biopsies. Contemp Clin Trials 2012;33(5):881-8.
111. Lin Z, Lo A, Simeone DM, Ruffin MT, Lubman DM. An n-glycosylation analysis of human alpha-2-macroglobulin using an integrated approach. J Proteomics Bioinform 2012;5:127-34.
112. Patel DA, Rozek LS, Colacino JA, Van Zomeren-Dohm A, Ruffin MT, Unger ER, Dolinoy DC, Swan DC, Onyekwuluje J, Degraffinreid CR, Paskett ED. Patterns of cellular and HPV 16 methylation as biomarkers for cervical neoplasia. J Virol Methods 2012;184(1-2):84-92.
113. Ruffin, MT, IV, Hade EM, Gorsline MR, DeGraffinreid CR, Katz ML, Kobrin SC, Paskett ED. Human papillomavirus vaccine knowledge and hypothetical acceptance among women in Appalachia Ohio Vaccine. Vaccine 2012;30(36):5349-57.
114. Wang C, Sen A, Ruffin MT, IV, Nease DE, Jr., Gramling R, Acheson LS, O’Neill SM, Rubinstein WS; for the Family HealthwareTM Impact Trial (FHITr) Group. Family history assessment: impact on disease risk perceptions. Am J Prev Med 2012;43(4):392-8.
115. Kelly KM, Ferketich AK, Ruffin MT IV, Tatum C, Paskett ED. Perceived risk of cervical cancer in Appalachian women. Am J Health Behav 2012:36(6):849-59.
116. Azrad M, Zhang K, Vollmer RT, Madden J, Polascik TJ, Snyder DC, Ruffin MT, Moul JW, Brenner D, Hardy RW, Demark-Wahnefried W. Prostatic alpha-linolenic acid (ALA) is positively associated with aggressive prostate cancer: A relationship which may depend on genetic variation in ALA metabolism. PLoS One 2012;7(12):e53104.
117. Citronberg J, Bostick RM, Ahearn TU, Turgeon DK, Ruffin MT, Djuric Z, Sen A, Brenner DE, Zick SM. Effects of ginger supplementation on cell cycle biomarkers in the normal-appearing colonic mucosa: results from a pilot, randomized, controlled trial. Cancer Prev Res (Phila) 2013;6(4):271-81.
118. Jimbo M, Rana GK, Hawley S, Holmes-Rovner M, Kelly-Blake K, Nease DE Jr, Ruffin MT 4th. What is lacking in current decision aids on cancer screening? CA Cancer J Clin 2013;63(3):193-214.
119. Azrad M, Vollmer RT, Madden J, Dewhirst M, Polascik TJ, Snyder DC, Ruffin MT, Moul JW, Brenner DE, Demark-Wahnefried W. Flaxseed-derived enterolactone is inversely associated with tumor cell proliferation in men with localized prostate cancer. J Med Food 2013;16(4):357-60.
120. Sen A, Ren J, Ruffin MT, Turgeon DK, Brenner DE, Sidahmed E, Rapai ME, Cornellier ML, Djuric Z. Relationships between serum and colon concentrations of carotenoids and fatty acids in randomized dietary intervention trial. Cancer Prev Res (Phila) 2013;6(6):558-65.
121. Nie S, Lo A, Zhu J, Wu J, Ruffin MT, Lubman DM. Isobaric protein-level labeling strategy for serum glycoprotein quantification analysis by liquid chromatography-tandem mass spectrometry. Anal Chem 2013;85(11):5353-7.
122. Post DM, Gehlert S, Hade EM, Reiter PL, Ruffin M, Paskett ED. Depression and SES in women from Appalachia. Journal of Rural Mental Health 2013;37(1):2-15.
123. Jiang Y, Turgeon DK, Wright BD, Sidahmed E, Ruffin MT, Brenner DE, Sen A, Zick SM. Effect of ginger root on cyclooxygenase-1 and 15-hydroxyprostaglandin dehydrogenase expression in colonic mucosa of humans at normal and increased risk for colorectal cancer. Eur J Cancer Prev 2013;22(5):455-60.
124. Reiter PL, Katz ML, Ruffin MT, Hade EM, DeGraffenreid CR, Patel DA, Paskett ED, Unger ER. HPV prevalence among women from Appalachia: results from the CARE Project. PLOS ONE 2013;8(10).
125. de la Cruz MD, Young AP, Ruffin MT IV. HPV testing for normal cervical cytology in low-risk women age 30-65 years by family physicians. J Am Board Fam Med 2013;26(6):720-7.
126. Jimbo M, Kelly-Blake K, Sen A, Hawley ST, Ruffin IV MT. Decision Aid to Technologically Enhance Shared decision making (DATES): study protocol for a randomized controlled trial. Trials 2013;14(1):381.
127. Jimbo M, Shultz CG, Nease DE, Fetters MD, Power D, Ruffin MT 4th. Perceived barriers and facilitators of using a web-based interactive decision aid for colorectal cancer screening in community practice settings: findings from focus groups with primary care clinicians and medical office staff. J Med Internet Res 2013;15(12):e286.
128. Lin Z, Yin H, Lo A, Ruffin MT, Anderson MA, Simeone DM, Lubman DM. Label-free relative quantification of alpha-2-macroglobulin site-specific core-fucosylation in pancreatic cancer by LC-MS/MS. Electrophoresis 2014;35(15):2108-15.
129. Katz ML, Oldach BR, Goodwin J, Reiter PL, Ruffin MT 4th, Paskett ED. Development and initial feedback about a human papillomavirus (hpv) vaccine comic book for adolescents. J Cancer Educ 2014;29(2):318-24.
130. Nie S, Lo A, Wu J, Zhu J, Tan Z, Simeone DM, Anderson MA, Shedden KA, Ruffin MT, Lubman DM. Glycoprotein biomarker panel for pancreatic cancer discovered by quantitative proteomics analysis. J Proteome Res 2014;13(4):1873-84.
131. de la Cruz MD, Young AP, Ruffin MT IV. Diagnosis and management of pancreatic cancer. Am Fam Physician 2014;89(8):626-32.
132. Turgeon DK, Ruffin MT 4th. Screening strategies for colorectal cancer in asymptomatic adults. Prim Care 2014;41(2):331-53.
133. Zackular JP, Rogers MA, Ruffin MT 4th, Schloss PD. The human gut microbiome as a screening tool for colorectal cancer. Cancer Prev Res (Phila) 2014;7(11):1112-21.
134. Resnicow K, Zhou Y, Hawley S, Jimbo M, Ruffin MT, Davis RE, Shires D, Lafata JE. Communication preference moderates the effect of a tailored intervention to increase colorectal cancer screening among African Americans. Patient Educ Couns. 2014;97(3):370-5.
135. Li Y, Sen A, Ren J, Askew LM, Sidahmed E, Brenner DE, Ruffin MT 4th, Turgeon DK, Djuric Z. Effects of vitamin e from supplements and diet on colonic α- and γ-tocopherol concentrations in persons at increased colon cancer risk. Nutr Cancer 2015;67(1):73-81.
136. Nie S, Yin H, Tan Z, Anderson MA, Ruffin MT, Simeone DM, Lubman DM. Quantitative analysis of single amino acid variant peptides associated with pancreatic cancer in serum by an isobaric labeling quantitative method. J Proteome Res 2014;13(12):6058-66.
137. Carere DA, Couper MP, Crawford SD, Kalia SS, Duggan JR, Moreno TA, Mountain JL, Roberts JS, Green RC; PGen Study Group. Design, methods, and participant characteristics of the Impact of Personal Genomics (PGen) Study, a prospective cohort study of direct-to-consumer personal genomic testing customers. Genome Med 2014;6(12):96.
138. Tan Z, Yin H, Nie S, Lin Z, Zhu J, Ruffin MT, Anderson MA, Simeone DM, Lubman DM. Large scale identification of core-fucosylated glycopeptide sites in pancreatic cancer serum using mass spectrometry. J Proteome Res 2015;14(4):1968-78.
139. Djuric Z, Turgeon DK, Ren J, Neilson A, Plegue M, Waters IG, Chan A, Askew L, Ruffin IV M, Sen A, Brenner D. Effects of a Mediterranean Diet intervention on anti- and pro-inflammatory eicosanoids, epithelial proliferation, and nuclear morphology in biopsies of normal colon tissue. Nutr Cancer 2015;14:1-9.
140. Wang C, Sen A, Plegue M, Ruffin MT 4th, O’Neill SM, Rubinstein WS, Acheson LS, the Family HealthwareTM Impact Trial (FHITr) Group. Impact of family history assessment on communication with family members and health care providers: a report from the Family HealthwareTM Impact Trial (FHITr). Prev Med 2015;77:28-34.
141. Azrad M1, Vollmer RT, Madden J, Polascik TJ, Snyder DC, Ruffin MT 4th, Moul JW, Brenner D, He X, Demark-Wahnefried W. Disparate results between proliferation rates of surgically excised prostate tumors and an in vitro bioassay using sera from a positive randomized controlled trial. Biotech Histochem. 2015;90(3):184-9.
142. Zazove P, Plegue MA, Uhlmann WR, Ruffin MT. Prompting primary care providers about increased risk due to family history: does it work? J Am Board Fam Med 2015 5/6;28(3):334-42.
143. Ruffin IV MT, Plegue MA, Rockwell PG, Young AP, Patel DA, Yeazel MW. Impact of electronic health record (EHR) reminder on human papillomavirus (HPV) vaccine initiation and timely completion. JABFM 2015 5/6;28(3):324-333.
144. Ostergren JE, Gornick MC, Carere DA, Kalia SS, Uhlmann WR, Ruffin MT, Mountain JL, Green RC, Roberts JS. How well do customers of direct-to-consumer personal genomic testing services comprehend genetic test results? findings from the Impact of Personal Genomics Study. Public Health Genomics 2015;18(4):216-24.
145. Meisel SF, Carere DA, Wardle J, Kalia SS, Moreno TA, Mountain JL, Roberts JS, Green RC; PGen Study Group. Explaining, not just predicting, drives interest in personal genomics. Genome Med 2015;7(1):74.
146. Carere DA, VanderWeele T, Moreno TA, Mountain JL, Roberts JS, Kraft P, Green RC; PGen Study Group. The impact of direct-to-consumer personal genomic testing on perceived risk of breast, prostate, colorectal, and lung cancer: findings from the PGen study. BMC Med Genomics 2015;8:63.
147. Ursu A, Sen A, Ruffin M. Impact of cervical cancer screening guidelines on chlamydia screening. Ann Fam Med 2015;13(4):361-3.
148. Zick SM, Turgeon DK, Ren J, Ruffin MT, Wright BD, Sen A, Djuric Z, Brenner DE. Pilot clinical study of the effects of ginger root extract on eicosanoids in colonic mucosa of subjects at increased risk for colorectal cancer. Mol Carcinog 2015;54(9):908-15.
149. Umoh FI, Kato I, Ren J, Wachowiak PL, Ruffin MT 4th, Turgeon DK, Sen A, Brenner DE, Djuric Z. Markers of systemic exposures to products of intestinal bacteria in a dietary intervention study. Eur J Nutr 2016;55(2):793-8.
150. van der Wouden CH, Carere DA, Maitland-van der Zee AH, Ruffin IV, MT, Roberts JS, Green RC, for the Impact of Personal Genomics Study Group. Consumer perceptions of interactions with primary care providers after direct-to-consumer personal genomic testing. Ann Intern Med 2016;164(8):513-22.
151. Baxter NT, Ruffin IV MT, Rogers MAM, Schloss PD. Microbiota-based model improves the sensitivity of fecal immunochemical test for detecting colonic lesions. Genome Med 2016;8:37.
152. Sidahmed E, Sen A, Ren J, Patel A, Turgeon DK, Ruffin MT, Brenner D, Djuric Z. Colonic saturated fatty acid concentrations and expression of cox-1, but not diet, predict prostaglandin e2 in normal human colon tissue. Nutr Cancer, 2016 Aug 22:1-10. [Epub ahead of print]
Non Peer-Reviewed Publications:
1. Ruffin MT. Musculoskeletal system and the effects of aging. Internal Med World Report 1990;5:13-5.
2. Ruffin MT. HIV and the health care worker. AIDS: Medical Report 1990;3:64-69.
3. Ruffin MT. Arthroscopy for elderly knees. Emerg Med 1990;22:94-9.
4. Ruffin MT. Reliability of Pap smear reports (invited editorial). Fam Pract Res J 1991;11(2):133-8.
5. Ruffin MT. Cervical cancer screening: Issues of collection tools and reporting (invited editorial). Arch Fam Med 1993;2(3):261-3.
6. Ruffin MT, Kiningham RB. Anterior knee pain (letter). Am Fam Phys 1993;48:1395.
7. Green LA, Ruffin MT. Chest pain and MI (letter). J Fam Pract 1993;37:118-9.
8. Ruffin MT. Cervical cancer screening (letter). Arch Fam Med 1993;2:1114-5.
9. Smith MA, Ruffin MT, Green LA. A place for electronic fetal monitoring during labor (letter). Am Fam Phys 1994;49:749-57.
10. Fischer G, Fetters MD, Ruffin MT. Vaginal smears after hysterectomy (letter). J Fam Pract 1995;41(1):16.
11. Ruffin MT, Bland CJ. Promotion of women physicians in academic medicine (letter). JAMA 1995;274(14):1133-4.
12. Ruffin MT, Klinkman MS, Fetters MD, Green LA. Screening for prostate cancer (letter). JAMA 1995;273(15):1175.
13. Ruffin MT. Can we change physicians’ practices in the delivery of cancer-preventive services (invited editorial)? Arch Fam Med 1998;7(4):317-9.
14. Sonis J, Doukas D, Klinkman M, Reed B, Ruffin MT. Applicability of clinical trial results to primary care (letter to the Editor). JAMA 1998;280(20):1746.
15. Shakour S, Ruffin MT, Zick SM, Lubman DM, Nie S. Serum metabolomic analysis of pancreatic cancer--Letter. Cancer Epidemiol Biomarkers Prev 2013 Oct;22(10):1921.
16. Ruffin M. Combined HPV and cytology better than cytology for protection against cervical cancer (letter). Evid Based Med 2014;19(4):148.
17. Pendleton E, Ruffin MT, Harper DM. No evidence in US of HPV16/18 cancer precursor reduction (letter). Vaccine 2016;34(2):200.
18. Ewigman B, Davis A, Vansaghi T, Cole A, deGruy F, Green L, King D, Kuzel T, Lindbloom E, Meadows L, Miser F, Nease D, Ruffin M. Building research & scholarship capacity in departments of family medicine: a new joint ADFM-NAPCRG initiative (commentary). Ann Fam Med 2016;14(1):82-3.
Book:
1. Ruffin MT 4th, Shultz CG. Screening and prevention in primary care. Prim Care 2014;41(2):xvii-xviii.
Book Chapters:
1. Smith MA, Ruffin MT. Obstetrics, (in) Saunders' Review of Family Practice, (ed) Bope E, Cass AR, Hagen M, W. B. Saunders Co., Philadelphia, Pennsylvania, 1993.
2. Smith MA, Ruffin MT. Antepartum care, (in) Conn's Current Therapy, (ed) Rakel RE, W. B. Saunders Co., Philadelphia, Pennsylvania, 1993.
3. Rock CL, Coulston AM, Ruffin MT. Diet therapy, (in) Harrison's Principles of Internal Medicine, (eds) Fauci AS, Braunwald E, Isselbacker KJ, Wilson JD, Martin JB, Kasper DL, Hauser SL, Longo DL, ed 14. New York, NY: McGraw-Hill, 1998:465-472.
4. Krishnan K, Ruffin MT, Brenner DE. Aspirin and other prostaglandin inhibitors for the prevention of colon cancer, (in) Infusion Chemotherapy-Irradiation Interactions, (ed) Rosenthal CJ, Rotman M. Amsterdam, The Netherlands: Elsevier, 1998:405-422.
5. Paskett ED, Wewers ME, Ruffin MT IV. Educational strategies for the prevention of cervical cancer, (in) Cervical Cancer: From Etiology to Prevention, (ed) Rohan TE, Shah KV: Kluwer Academic Publishers: The Netherlands, 2004:237-260.
6. Shureiqi, Reddy, Ruffin, Brenner. Prevention and screening principles relevant to gastrointestinal malignancies, (in) Gastrointestinal Oncology, (ed) Abbruzzese, Evans, Willett and Feoglio-Preiser, Oxford University Press: New York, NY, 2003.
7. Ruffin MT IV, Rock CL. Human Papillomavirus infection in men and women: The impact of nutrition on cervical cancer, (in) Principles of Gender-Specific Medicine, (ed) Legato M: Elsevier Academic Press: San Diego, CA, 2004:796-812.
8. Nease DE, Stoffel E, Turgeon DK, Ruffin MT, IV. Colorectal Cancer Screening. Clin Fam Pract, 2004:6(3):693-707.
9. Unger ER, Ruffin MT, IV, Diaz-Arrastia C. Human Papillomaviruses, (in) Clinical Gynecology, (ed) Bieber EJ, Sanfilippo JS, Horowitz IR: Churchill Livingstone: Canada, 2006:305-314.
10. Young AP, de la Cruz MSD, Ruffin MT. Clinical Utility of HPV Testing in Cervical Cancer Screening (in) Handbook of Human Papillomavirus: Prevalence, Detection and Management, (ed) Smith HB: Nova Sciences Publishers, Inc.: ebook, 2013:213-40.
11. Harper DM, Ruffin MT IV. Screening for Gynecologic Malignancies, (in) Oncology in Primary Care, (ed) Rose Mg, Devita VT Jr, Lawrence TS, Rosenberg SA: Lippincott Williams & Wilkins: Philadelphia, PA, 2013:66-72.
12. Unger ER, Ruffin MT, Diaz-Arrastia C. Human Papillomaviruses, (in) Clinical Gynecology, ed 2 (ed) Bieber EJ, Sanfilippo JS, Horowitz IR, Shafi MI: Cambridge University Press: New York, NY, 2015:371-81.
13. Young AP, de la Cruz MSD, Ruffin MT, IV. Diseases of the Pancreas, (in) Family Medicine: Principles and Practice, ed 7. (ed) Paulman P, Taylor RB: Springer: Heidelberg, Germany, in press.
Abstracts:
1. Ruffin MT, Krishnan K, Kraus E, Kelloff G, Boone C, Vaerten M, Bromberg J, Rock C, Boland CR, Brenner DE. Aspirin as a chemopreventive agent for colorectal cancer: modulation of gut epithelial prostaglandins (PG) to a single daily aspirin dose (abstract). Proc Am Assoc. Cancer Res 1994;35:309.
2. Burney KD, Krishnan K, Ruffin MT, Brenner DE. Adherence to aspirin in a Phase 1 chemoprevention trial in normal subjects: implications for future chemoprevention trials (abstract). Cancer Epidemiol Biomarkers Prev 1995;5:181.
3. Thiessen JJ, Jong P, Ruffin MT, Krishnan K, Crowell J, Vaerten M, Moore M, Brenner DE. A limited blood sampling strategy to estimate acetylsalicylic acid (ASA) and salicylic acid (SA) exposure in patients (abstract). Proceedings Am Assoc Cancer Res 1995;36:235.
4. Ruffin MT, Ogaily MS, Johnston CM, Gregoire L, Lancaster WD, Brenner DE. Surrogate endpoint biomarkers for cervical cancer chemoprevention trials (abstract). J Cell Biochem 1995;59(S23):113-24.
5. Emenhiser C, Lovalvo JL, Rock CL, Ruffin MT, Schwartz SJ. Geometrical ß-carotene isomers in human cervical tissue (abstract). FASEB J 1996;10:A242.
6. Lovalvo JL, Rock CL, Ruffin MT, Emenhiser C, Disario W, Schwartz SJ. ß-carotene uptake from processed versus raw vegetables in women (abstract). FASEB J 1996;10:A732.
7. Krishnan K, Ruffin MT, Shah R, Vaerten MA, Peters-Golden M, Boland CR, Brenner DE. Relationship of human colorectal epithelial cyclooxygenase (Cox-1) to aspirin and salicylic acid pharmacology and tissue prostaglandins E2 and F2 (abstract). Proceedings Am Assoc Cancer Res 1996;37:598.
8. Ruffin MT, Screening for prostate cancer (abstract). J Fam Pract 1999;48(8):581-2.
9. Ruffin MT, Baron J. Recruiting subjects in cancer prevention and control studies (abstract). J Cell Biochem 2000;77(S34):80-3.
10. Ruffin MT, Normolle DP, Heath DD, Bailey JM, Murray SI, Boggs ME, Crowell JA, Rock CL, Brenner DE. Dose escalation of curcumin in healthy adults (abstract). Cancer Epidemiol Biomarkers Prev 2003;12(11):1324S.
11. Ruffin MT, Bailey JM, Normolle DP, Michael CW, Bieniasz ME, Fonde KR, Johnston CM, Reed BD, Brenner DE, Kmak DC, Unger ER. Topical all-trans retinoic acid in high grade squamous intraepithelial lesions (abstract). Cancer Epidemiol Biomarkers Prev 2003;12(11):1352S.
12. Steinau M, Habis AH, Lee DR, Vernon SD, Ruffin MT, Verna M, Srivastava S, Unger ER. Molecular signatures of cervical neoplasia: A pilot study of gene expression profiling in exfoliated cervical cells (abstract). FASEB J 2004;18(5):A936.
13. Rajeevan MS, Swan D, Nisenbaum RA, Lee DR, Vernon SD, Ruffin M, etc. Absence of HPV 16 E6/E7 deregulation in preinvasive cervical neoplasia (abstract). Proceedings 21st International Papillomavirus Conference 2004;page 290.
14. Ruffin MT IV, Bailey JM, Swan DC, Patel S, Lee DR, Unger, ER. Absence of human papillomavirus in amniotic fluid (abstract). Proceedings 22nd International Papillomavirus Conference 2005;page 285.
15. Steinau M, Rajeevan MS, Lee DR, Vernon SD, Ruffin MT, Horowitz IR, Flowers LC, Tagros TS, Birdsong G, Husain M, Unger ER. Validation of gene expression biomarkers for cervical intraepithelial neoplasia (abstract). FASEB J 2006;20(5):A1326.
16. Jimbo M, Ruffin M, Nease D, Fetters, MD, Strecher V, Saunders E. Cancer Screening adherence through technology-enhanced shared decision making (CSATS) (abstract). 34th Annual Meeting of the North American Primary Care Research Group, 2006, Tucson, Arizona. Available at: .
17. Nease D Jr., Green L, Gorenflo D, Underwood J, Ruffin M. Prompting and reminding at encounters for prevention (PREP): Impact of a reminder system on colorectal cancer screening in diverse practices (abstract). 34th Annual Meeting of the North American Primary Care Research Group, 2006, Tucson, Arizona. Available at: .
18. Jimbo M, Ruffin M, Nease D, Fetters, MD, Strecher V, Saunders E. Cancer screening adherence through technology-enhanced shared decision making. Family Medicine Digital Resources Library 2006.
Available at:
19. Wang C, O’Neill SM, Rothrock N, Gramling R, Sen A, Acheson LS, Rubinstein WS, Nease DE, Ruffin MT. Comparison of risk perceptions and worry across six common chronic diseases (abstact). Ann Behav Med 2008;35(S1):S77.
20. Ellsworth JS, Collado B, Strawder T, Downey A, Ruffin MT, Djuric Z. Formulation of implementation intentions for improving fruit and vegetable intakes (abstract). J Am Diet Assoc 2008;108(9 Suppl):A59.
21. Qiu YH, Patwa TH, Xu L, Shedden K, Misek DE, Ruffin MT, Brenner DE, Lubman DM. Plasma glycoprotein profiling for colorectal cancer biomarker identification by lectin glycoarray and lectin blot. Cancer Biomarkers 2008;4(3):171.
22. Tuck MK, Normolle DP, Anan-Dasabapathy S, Turgeon DK, Poneros J, Stoffel E, Marcon N, Appelman H, Ruffin M, Arber N, Bresalier R, Anton K, Thomason M, Baron JH, Syngal S, Brenner DE. Colon and esophagus reference sets. Cancer Biomark 2008;4(3):164-65.
23. Anandasabapathy S, Turgeon DK, Normolle D, Tuck M, Poneros J, Stoffel E, Syngal S, Marcon N, Baron J, Ruffin M, Appelman H, Arber N, Bresalier R, Brenner D. Biorepository for validation of biomarkers predictive of the progression of Barrett's esophagus. Cancer Biomark 2008;4(3):129.
24. Wang C, O'Neill SM, Rothrock N, Gramling R, Sen A, Acheson LS, Rubinstein WS, Nease DE, Ruffin MT. Comparison of risk perceptions and worry across six common chronic diseases. Ann Behav Med 2008;35(S1):S77.
25. O'Neill SM, Rubinstein WS, Wang C, Yoon PW, Acheson LS, Rothrock N, Starzyk EJ, Beaumont JL, Galliher JM, Ruffin MT, Family Healthware TM Impact Trial. Familial risk for common diseases in primary care The Family Healthware (TM) Impact Trial. Am J Prev Med 2009;36(6):506-14.
26. Carlos RC, Ruffin M, Dempsey AF, Patel DA, Resnicow K, Dalton VA. HPV vaccine uptake in adolescent daughters of mother who receive cancer preventive services. J Womens Health 2010;19(3):608-9.
27. Wang C, Gramling R, Sen A, Ruffin MT, Nease DE, Acheson LS, O'Neill SM, Rubinstein WS. The impact of family history assessment on disease risk perceptions: results from The Family Healthware Impact Trial (FHITR). Ann Behav Med 2010;39(S1):148.
28. Ruffin MT, Hade E, DeGraffinreid C, Paskett ED. Predictors of abnormal cervical cytology among women in Ohio Appalachia. Ann Behav Med 2010;39(S1):122.
29. Paskett ED, Ferketich A, Ruffin MT, Thompson B. Cervical cancer prevention among women living in rural populations: the example of Ohio Appalachia. Ann Behav Med, 2010;39(S1):121.
30. Dempsey AF, Cohn L, Dalton V, Ruffin MT. HPV vaccine utilization by young adult women: are the highest risk populations being vaccinated? J Womens Health 2010;19(10):1796.
31. Wang C, Sen A, Nease D, Ruffin M, Gramling R, Acheson L, O'Neill SM, Rubinstein W. Impact of familial risk assessment for chronic diseases on perceptions of risk and worry: a study of dose and disease effects. Ann Behav Med 2011;41(Suppl 1):S39.
32. Kelly KM, Ferketich A, Ruffin M, Tatum C, Paskett E. Perceived risk of cervical cancer in appalachian women. Ann Behav Med 2011;41(Suppl 1):S258.
33. Zick SM, Bostick RM, Ruffin M, Turgeon K, Wright BD, Brenner D. Ginger supplementation and the expression of NF-KB in the normal-appearing colorectal mucosa of patients at high risk of colorectal cancer: results from a pilot randomized, controlled trial. Pharm Biol 2012;50(5):629.
34. Citronberg J, Bostick RM, Ruffin M, Turgeon DK, Brenner DE, Wright BD, Zick SM. Ginger supplementation and the expression of BAX in the normal-appearing colorectal mucosa of sporadic colorectal adenoma patients: results from a pilot randomized, controlled trial. Pharm Biol 2012;50(5):629-30
35. Jiang Y, Turgeon DK, Wright BD, Ruffin MT, Brenner DE, Zick SM. Regulation of ginger root extract on colonic inflammatory signaling in human with normal and high risk of colon cancer. Pharm Biol 2012;50(5):540.
36. Nguyen D, Tuck M, Sen A, Ruffin MT, Baron JA, Bresalier RS, Marcon NE, McConnell D, Stoffel EM, Syngal S, Brenner DE, Turgeo, DK. Sensitivity and specificity of fecal immunochemical and guaiac testing for occult blood in archived frozen stool samples. Gastroenterology 2012;142(S5):S155.
37. Perrault JT, Ogbemudia BE, Sears ML, DeGraffinreid CR, Zhu DQ, Lu B, Cohn DE, Knobloch TJ, Ruffin MT, Paskett ED, Weghorst CM. A CD83 SNP is associated with abnormal Pap test results in high-risk Ohio Appalachian women. Cancer Res 2013;73(8 S1):1351.
38. Wang C, Dalia A, Roberts JS, Kalia S, Chen C, Ruffin M, Lehmann L, Mountain J, Moreno T, Green RC. Decisions to share results and seek further information following online personal genetic testing. Ann Behav Med 2014;47(S1):S162-S162.
39. Umoh F, Ren JW, Ruffin M, Turgeon D, Sen A, Brenner D, Djuric Z. Independent effects of BMI, CRP and carotenoids, but not diet change, on LPS binding protein concentrations. FASEB J 2014;28(1 S):825.2
40. Katz ML, Reiter PL, Ruffin MT, Paskett ED. Development of a multilevel human papillomavirus (HPV) vaccine intervention. Proceedings of the 7th AACR Conference on The Science of Cancer Health Disparities 2014;page 110.
41. Katz ML, Goodwin J, Reiter PL, Ruffin MT, Paskett ED. Development and initial feedback about a human papillomavirus (HPV) vaccine comic book for adolescents. Cancer Epi Biomarkers Prev 2014;23(11):A23.
42. Sidahmed E, Sen A, Ren JW, Turgeon K, Ruffin M, Brenner D, Djuric Z. Relationships of prostaglandin E-2 with fatty acid concentrations and gene expression in colon of individuals at increased risk of colon cancer. FASEB J 2015;29(1):753.9
MTR/jb
08/23/16
................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related searches
- university of michigan admissions staff
- university of michigan admission requirement
- university of michigan sat scores
- university of michigan payroll office
- university of michigan application deadline
- university of michigan act requirements
- university of michigan entrance requirements
- university of michigan transfer deadline
- university of michigan philosophy dept
- university of michigan applicant portal
- university of michigan neurology
- university of michigan hospital neurology